Health & Information | IDL Biotech
IDL Biotech


German study recommends UBC® Rapid to be added in the diagnostics and follow-up of high risk bladder cancer

International Journal of Molecular Sciences has published a study on UBC® Rapid. In total 530 urine samples was included in the multicenterstudy.

6 things you need to know about Bladder Cancer

IDL Biotech

Skip this intro